Table 1.
Definitions, non-digital, and digital examples for eight biomarker types.
Type | Definitiona | Non-digital example | Digital example |
---|---|---|---|
Resilience biomarkerb | A specific type of a diagnostic, monitoring, or response biomarker measured as the response to an external challenge to reflect the resilience of the biological system | Cytokine response to the PhenFlex challenge indicates low inflammatory resilience in metabolically compromised individuals (25) | Continuous glucose variation is higher in prediabetic and diabetic individuals with glucose dysregulation (26) |
Diagnostic biomarker | A biomarker used to detect or confirm presence of a health status, disease or condition of interest or to identify individuals with a health or disease subtype. | Increased fasting plasma glucose or hemoglobin A1c indicate the presence of type 2 diabetes | Atrial fibrillation is diagnosedc using photoplethysmography in a smart watch (27) |
Monitoring biomarker | A biomarker measured serially for assessing status of health or a disease or medical condition or for evidence of exposure to (or effect of) a medical product, a lifestyle change, or an environmental agent | Regular glucose finger pricks are used to manage insulin administration in type 1 diabetes patients | Calibration-free continuous glucose monitoring is used for monitoring type 2 diabetes patients (28) |
Response biomarker | A biomarker used to show that a biological response has occurred in an individual who has been exposed to a medical product, a lifestyle change, or an environmental agent | Serum LDL cholesterol reduction with cholesterol lowering agents or lifestyle changes | Hyperglycemic peak reduction with exercise as an add-on intervention in type 2 diabetes patients using metformin (29). Hyperglycemic peaks were measured with continuous glucose monitoring |
Predictive biomarker | A biomarker used to identify individuals who are more likely than similar individuals without the biomarker to experience a favorable or unfavorable effect from exposure to a medical product, a lifestyle change, or an environmental agent | Individuals with insulin resistance in the muscle benefit from a Mediterranean diet, whereas individuals with insulin resistance in the liver mostly benefit from a low-fat diet (30) | Wearable heart rate, skin conductance, skin temperature, and activity patterns were used to define digital phenotypes characterized by poor health indicators and high depression, anxiety and stress scores (31) |
Prognostic biomarker | A biomarker used to identify likelihood of a clinical event, disease recurrence or progression in patients who have the disease or medical condition of interest. | Augmented C-reactive protein (CRP) levels indicate increased likelihood of recurrent artery disease events in patients with unstable angina | Spatial memory, prospective memory, executive function, and psychomotor processing speed were assessed with a smartphone app to define a prognostic biomarker for progression to dementia in people with mild cognitive impairment (32) |
Safety biomarker | A biomarker measured before or after an exposure to a medical product, a lifestyle change, or an environmental agent to indicate the likelihood, presence, or extent of toxicity as an adverse effect | Increased levels of plasma creatinine phosphokinase indicate statin intolerance in the muscles (33) | QT prolongation, a cardiac safety biomarker, was reliably identified using a wearable ECG monitoring system (34) |
Susceptibility/risk biomarker | A biomarker that indicates the potential for developing a disease or medical condition in an individual who does not currently have clinically apparent disease or the medical condition | High CRP levels indicate greater likelihood of developing incident coronary disease (35) | Autonomic imbalance, measured by reduced heart rate variability, may serve as a risk factor for cardiovascular disease (36) |
Definitions are adapted from BEST glossary also include health status and lifestyle interventions (24);
Added to the list to highlight the specific characteristic of a resilience biomarker;
At the moment, this is not a medical diagnosis.